ArticleFrontiers in human neuroscience2026
Atypical MRI presentation of symmetrical thalamic and basal ganglia lesions in adult-onset MOG-IgG-associated disease: a case report.
Article in Frontiers in human neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is a rare autoimmune neurological condition characterized by clinical phenotypes that include acute disseminated encephalomyelitis, optic neuritis, and transverse myelitis. Neuroimaging features differ markedly between adults and children, and brain lesions are relatively uncommon in adult MOGAD patients. Atypical imaging patterns can complicate the differentiation of MOGAD from other diseases. We report a 21-year-old female presenting with dysarthria, gait deviation, blurred vision, and slow response. Brain MRI revealed multiple patchy, irregular T2-FLAIR hyperintense lesions involving the pons, midbrain, and strikingly symmetric bilateral thalami and basal ganglia. She had a history of chronic alcohol use and was initially misdiagnosed with Wernicke's encephalopathy. No symptomatic improvement followed vitamin B1 supplementation. Serum and cerebrospinal fluid (CSF) analysis revealed low-positive myelin oligodendrocyte glycoprotein immunoglobulin G (MOG-IgG). After carefully excluding other differential diagnoses, a diagnosis of MOGAD was established. High-dose intravenous methylprednisolone followed by oral tapering resulted in significant clinical improvement, along with marked amelioration of MRI abnormalities. This case highlights an atypical adult MOGAD presentation with widespread brainstem to the basal ganglia and symmetric thalamic lesions. It underscores the importance of recognizing such imaging patterns to avoid misdiagnosis and prompt timely autoantibody testing and immunotherapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.